Amedisys, Inc. (NASDAQ:AMED) Given Average Rating of "Hold" by Analysts

Shares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have been assigned a consensus rating of "Hold" from the five analysts that are covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $100.75.

A number of brokerages have weighed in on AMED. Stephens reaffirmed an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th.

Amedisys Trading Down 0.4%

AMED stock traded down $0.43 during trading on Wednesday, reaching $97.46. The company had a trading volume of 635,871 shares, compared to its average volume of 420,106. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a market cap of $3.20 billion, a P/E ratio of 35.96, a PEG ratio of 1.32 and a beta of 0.94. The business has a 50 day moving average of $94.66 and a 200 day moving average of $92.22. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.29 and a quick ratio of 1.29.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The company had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. During the same period in the prior year, the firm earned $1.03 earnings per share. Amedisys's revenue was up 4.1% on a year-over-year basis. As a group, sell-side analysts forecast that Amedisys will post 4.4 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Amedisys

Institutional investors and hedge funds have recently made changes to their positions in the company. Hexagon Capital Partners LLC increased its position in shares of Amedisys by 108.1% during the first quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock valued at $29,000 after acquiring an additional 161 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of Amedisys by 56.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after acquiring an additional 120 shares in the last quarter. Fifth Third Bancorp increased its position in shares of Amedisys by 68.1% during the first quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after acquiring an additional 141 shares in the last quarter. Blue Trust Inc. increased its position in shares of Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after acquiring an additional 124 shares in the last quarter. Finally, UMB Bank n.a. increased its position in shares of Amedisys by 100.0% during the first quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock valued at $36,000 after acquiring an additional 193 shares in the last quarter. Institutional investors own 94.36% of the company's stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.